Navigation Links
Wilson Disease Screening Test

ProductsWilson Disease Screening Test
Company ARUP Laboratories
Item Wilson Disease Screening Test
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Wilson Vitreous Foreign Body Forceps
2. Wilson Pituitary Forceps
3. The Wilson Plus Radiolucent Wilson Frame
4. Wilson Lasik Marker
5. Wilson Disease Screening Panel, Serum
6. Anti-Gliadin IgG & IgA (Ab) EIA Gastrointestinal Markers 027-GD77 Celiac Disease Food Allergy
7. Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy
8. Anti-Gliadin IgA (Ab) EIA Gastrointestinal Markers 027-GD17 Celiac Disease Food Allergy
9. Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease
10. Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease
11. Siemens Webcast: Soarian Disease Management
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products:
(Date:11/21/2008)...PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc...ders overwhelmingly approved the proposals submitt...Teva Pharmaceuticals Industries Ltd. (Nasdaq: TE...verwhelming support of the transaction by the Barr...man and CEO. "We are pleased with the progress tha...
(Date:11/21/2008)...running increases production of neural stem cells ...In experiments in mice, exercise appears to revers...s usually seen with aging, Taiwanese researchers r...in,s ability to stave off aging appears to be due ...hat is essential for the production of new brain c...
(Date:11/21/2008)...re/ -- In a statewide survey, 33 physicians creden...ery at Presbyterian Hospital of Dallas were honore... " Super Doctors ." , , Each year, the publ...al Media, Inc. to survey more than 38,000 medical ...f you needed medical care, which doctor would you ...
(Date:11/21/2008)...21 A prestigious group of physicia...ather in Williamsburg, VA on March 27-29, 2009 at ...l information on cutting-edge therapeutic protocol...earch advances that impact patient care. The full ...information is available at www.bioconferences.co...
Breaking Medicine News(10 mins):Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Exercise Keeps the Brain Young 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2
...effect of the serving environment on alcohol relat...aid, "There is no reliable evidence that intervent...n reducing injury," fatal or otherwise. There were...ng, but if you’re only able to train 50 percent or...
...ood tests over skin tests for detecting people wit...ests are effective, reliable and therefore holds p...s people with the dormant TB infection never actua...e, yet it becomes imperative to detect such cases ...
...t there is an apparent increase in premature birth...tnessed in preterm deliveries between 1995 and 200...w risk women aged 20 – 40. The study had also focu... elective deliveries. All these complications also...
... has made a paradigm shift from being a generic dr...growth aggressively. // "We are rapidly transform...redients) manufacturer into an innovator for devel...molecules. "We believe this strategy will deliver...
Other Medicine News:Health News:Biocon To Shift Focus On Innovation To Accelerate Growth 2
(Date:11/20/2008)...ov. 20 GlaxoSmithKline (N...s Food and Drug Administration (FDA) granted accel...the treatment of thrombocytopenia in patients with...ura (ITP) who have had an insufficient response to...The approval is a significant milestone for PROMAC...
(Date:11/20/2008)...-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) an...Phase 1B,clinical trial of their lead drug candid..., at the Society for Integrative Oncology,s Fifth ...e Company,s oral presentation was selected,as a t...t of the Best of the,SIO Session on November 20, ...
(Date:11/20/2008)...-- PAREXEL International Corporation (Nasdaq: PR...provider, today announced that it has opened an of...g and clinical research capabilities. With the add...s throughout five important biopharmaceutical cent..., Brazil, Chile, and Mexico. This expansion furthe...
(Date:11/19/2008)...stical significance , , ISELIN, N.J., Nov. ...(Nasdaq: PARS ) today announced results from its...on (NE) drug delivery technology formulated with 3...center, randomized, double-blinded, placebo-contro...e Company,s 3% Diclofenac Diethanolamine NanoEmuls...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3079 1Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3079 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3079 3Massive American Red Cross Tornado Relief Effort Spans Five States 11169 1Massive American Red Cross Tornado Relief Effort Spans Five States 11169 2Customer Experience Conference Feb 25 27 3A Sharing New Insights on Winning Customer Loyalty 11165 1Customer Experience Conference Feb 25 27 3A Sharing New Insights on Winning Customer Loyalty 11165 2Best Practice Database 3A Complimentary Excerpt of Three Sales Force Excellence Studies 11162 1Best Practice Database 3A Complimentary Excerpt of Three Sales Force Excellence Studies 11162 2
... WIRE)--Apr 3, 2007 - Allon,Therapeutics Inc. (TSX... today the publication of new preclinical data fro...hat Allon,s product,candidate AL-108 significantly...he hyperphosphorylation of tau protein in the brai...don McCauley, Allon,s President and Chief Executiv...
...ewswire/ -- Southern,Research Institute, a not-for...ed research in the areas of preclinical drug,disco... scientists,will be delivering one oral presentati...n Association for Cancer Research,(AACR) Annual Me...Mittal Roy of Southern Research will be presenting...
Other Medicine Technology:Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 2Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's,Conference 3Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 2Southern Research Institute to Present at the 2007 American,Association For Cancer Research Annual Meeting 3